Genesis Healthcare, Inc. (NYSE:GEN) enjoyed a 17.26% run-up in share price since hitting record low of $1.1. The stock managed 4.88% rise and now stands at $1.29 as of 5/23/2019. At a recent session, the prices were hovering between $1.2 and $1.26. This company shares are 43.41% off its target price of $1.85 and the current market capitalization stands at $222.87M. The recent change has given its price a -3.73% deficit over SMA 50 and -54.9% deficit over its 52-week high. The stock witnessed -4.44% declines, -16.23% declines and -7.19% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found GEN’s volatility during a week at 6.98% and during a month it has been found around 5.04%.

Genesis Healthcare, Inc. (GEN) Top Holders

Institutional investors currently hold around $42 million or 33.3% in GEN stock. Look at its top three institutional owners: V3 Capital Management, L.P. owns $5.11 million in Genesis Healthcare, Inc., which represents roughly 2.29% of the company’s market cap and approximately 12.17% of the institutional ownership. Similar statistics are true for the second largest owner, First Washington Corp, which owns 3,468,587 shares of the stock are valued at $4.27 million. The third largest holder is Renaissance Technologies Llc, which currently holds $4.14 million worth of this stock and that ownership represents nearly 1.86% of its market capitalization.

Genesis Healthcare, Inc. 13F Filings

At the end of March reporting period, 32 institutional holders increased their position in Genesis Healthcare, Inc. (NYSE:GEN) by some 2,458,908 shares, 30 decreased positions by 1,976,123 and 23 held positions by 30,082,522. That puts total institutional holdings at 34,517,553 shares, according to SEC filings. The stock grabbed 10 new institutional investments totaling 289,351 shares while 9 institutional investors sold out their entire positions totaling 372,931 shares.

Genesis Healthcare, Inc. (NYSE:GEN) Insider Trades

Multiple company employees have indulged in significant insider trading. Genesis Healthcare, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that SVP and Treasurer Young Stephen Scott has sold 5,609 shares of Genesis Healthcare, Inc. (GEN) in the trading session dated May. 20, 2019. These shares are worth $6,731 and were traded at $1.2 each. The SEC filing shows that Sherman Michael Scott performed a sale of 6,398 shares. The SVP and General Counsel disposed these shares by way of transaction on May. 20, 2019. The company’s shares were given away at $1.2 per share worth to an income of some $7,678 to the account of Sherman Michael Scott.

EVP and Chief Nursing Officer, Reifsnyder JoAnne Susan, sold 7,990 common shares of Genesis Healthcare, Inc. (GEN) in the open market. In a transaction dated May. 20, 2019, the shares were put up for sale at an average price of $1.2, raking in a sum of $9,588. After this sale, 622,404 common shares of GEN are directly owned by the insider, with total stake valued at $802,901.

In the transaction dated May. 20, 2019, a great number of shares sold came courtesy the EVP and CFO; DiVittorio Thomas disposed a total of 10,318 shares at an average price of $1.2, amounting to approximately $12,382. The insider now directly owns 984,957 shares worth $1,270,595.

Genesis Healthcare, Inc. (GEN) Analyst Guide

Several analysts have released their opinion on Genesis Healthcare, Inc. (NYSE:GEN), with 1 analysts believing it is a strong buy. Whereas 3 of them predict the stock is a hold. Also, there are 0 buy, 1 sell and 0 strong sell ratings, collectively assigning a 2.8 average brokerage recommendation [T1].